DUBLIN--(BUSINESS WIRE)--The "Bone Graft and Substitutes - Global Market Outlook (2016-2022)" report has been added to Research and Markets' offering.
The Global Bone Graft and Substitutes market is expected to reach $4.33 billion growing at a CAGR of 5.3%. Bones in general have healing capacity but as a defect moves in ahead of it, surges and substitutes play a predominant role in the market.
Increasing demand from customers, due to aged population and more fracture cases, the market is being fuelled up by many favorable factors. But still the limited supply and high morbidity rates are the factors that are restraining the market growth.
The Spinal fusion in the application segment is dominating the Bone Graft and Substitutes market due to increase in number of aged population and demand for minimally invasive surgeries.
Bone Morphogenic Proteins (BMP) in types segment is anticipated to grow at a recognizable pace because of its advantages over allograft tissues, which present a potential risk of disease transmission, morbidity, and availability issues. While in geography segment North America is sharing the largest market revenue but Asia Pacific accounted for highest growth led by the huge aged population.
- Long Bone
- Foot and Ankle
- Spinal Fusion
- Demineralised Bone Matrix
Bone Graft Substitutes
- Bone Morphogenic Proteins (BMP)
- Synthetic Bone Grafts
Other Bone Graft Substitutes
Key Topics Covered:
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Bone Graft and Substitutes Market, By Application
6 Global Bone Graft and Substitutes Market, By Type
7 Global Bone Graft and Substitutes Market, By Geography
8 Key Developments
9 Company Profiling
- Baxter International, Inc.
- DePuy Synthes Companies
- Medtronic plc
- NuVasive, Inc.
- Orthofix Holdings, Inc.
- Stryker Corporation
- Wright Medical Technology, Inc.
Zimmer Biomet Holdings, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/zsx6rb/bone_graft_and